Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Receivables - Other: 2023-2024

Historic Receivables - Other for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $365,462.

  • Zhengye Biotechnology Holding's Receivables - Other rose 99.08% to $360,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $360,000, marking a year-over-year increase of 99.08%. This contributed to the annual value of $365,462 for FY2024, which is 98.37% up from last year.
  • As of FY2024, Zhengye Biotechnology Holding's Receivables - Other stood at $365,462, which was up 98.37% from $184,236 recorded in FY2023.
  • Over the past 5 years, Zhengye Biotechnology Holding's Receivables - Other peaked at $365,462 during FY2024, and registered a low of $184,236 during FY2023.
  • Moreover, its 2-year median value for Receivables - Other was $274,849 (2023), whereas its average is $274,849.
  • Data for Zhengye Biotechnology Holding's Receivables - Other shows a peak YoY soared of 98.37% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zhengye Biotechnology Holding's Receivables - Other stood at $184,236 in 2023, then spiked by 98.37% to $365,462 in 2024.